ArticleScientific reports2025
Ensemble-based eye disease detection system utilizing fundus and vascular structures.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Application of smooth OWA operators to classification of retinitis pigmentosa.Scientific reports · 2026Article
- SSLVNet: an explainable multi-modal hybrid framework integrating self-supervised learning and vision transformers for multi-label classification of retinal diseases.Frontiers in artificial intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal disorders, posing significant risks of the loss of vision or blindness, are increasingly prevalent, due to factors such as the aging population and chronic conditions like diabetes. Traditional diagnostic methods, relying on manually analyzing images, often have problems making an early detection and with their accuracy and efficiency, largely due to the subjectivity of human judgment and the time-consuming nature of the process. This study introduces a novel AI-based framework for diagnosing retinal disease, referred to as RetinaDNet. This framework leverages dual-branch input, incorporating both retinal images and vessel segmentation images, along with transfer learning and ensemble learning algorithms. This enhances the accuracy of the diagnoses and the stability of the model, particularly in scenarios with small sample sizes. By using vascular features and mitigating the risk of overfitting, this framework demonstrates superior performance in terms of multiple metrics. In particular, a soft voting classifier combined with the ResNet50 model attains accuracy rate of 99.2% on the diabetic retinopathy diagnosis task, and 98.8% on the retina disease classification task. The source code can be accessed at https://github.com/yu0809/Dual-branch-retinal-diseases .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.